AB Science (France) Investor Sentiment

AB Stock  EUR 0.79  0.01  1.25%   
About 62% of AB Science's investor base is looking to short. The analysis of current outlook of investing in AB Science SA suggests that many traders are alarmed regarding AB Science's prospects. The current market sentiment, together with AB Science's historical and current headlines, can help investors time the market. In addition, many technical investors use AB Science SA stock news signals to limit their universe of possible portfolio assets.
  
over six months ago at news.google.com         
AB Science announces publication in The Lancet of phase 3 clinical trial results demonstrating masit...
Google News at Macroaxis
over six months ago at news.google.com         
AB Science A new publication in the medical journal Muscle Nerve validates the use of the rate of de...
Google News at Macroaxis
over six months ago at news.google.com         
AB Science FY net loss widens to 27.7 million euros - Reuters
Google News at Macroaxis
over six months ago at news.google.com         
AB Science announces a slight delay in the publication of its 2023 annual financial report - Yahoo F...
Google News at Macroaxis
over six months ago at news.google.com         
Accor SA Short Interest Up 415.8 percent in April - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
AB Science provides a summary of the live webcast held on March 4, 2024 giving an update on AB Scien...
Google News at Macroaxis
over six months ago at news.google.com         
Health Canada Raises Concerns Over AB Sciences ALS Drug Submission - BNN Breaking
Google News at Macroaxis
over six months ago at news.google.com         
AB Science receives notice of allowance for European patent covering masitinib until 2036 in the tre...
Google News at Macroaxis
over six months ago at news.google.com         
Marcel Telles hands son Max his 6.1 billion stake in AB InBev - Fortune
Google News at Macroaxis
over six months ago at news.google.com         
Alzheimers Disease Therapeutics Market size to grow by USD 5.41 billion from 2023-2028 North America...
Google News at Macroaxis
over six months ago at news.google.com         
EPAM Systems, Inc. Short Interest Down 11.0 percent in ... - MarketBeat
Google News at Macroaxis
over a year ago at news.google.com         
AB Science will host a live webcast on Thursday November 30, 2023, from 3pm to 4pm CET, to present t...
Google News at Macroaxis
over a year ago at news.google.com         
Ecotoxicological Studies Market Set to Witness Massive Growth ... - Taiwan News
Google News at Macroaxis
over a year ago at news.google.com         
Duni Groups science-based targets approved -November 20, 2023 at 0131 am EST - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
Biogas Technology Industry Witness Highest Growth in near Future ... - Argyle Report
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about AB Science that are available to investors today. That information is available publicly through AB Science media outlets and privately through word of mouth or via AB Science internal channels. However, regardless of the origin, that massive amount of AB Science data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of AB Science news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of AB Science relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to AB Science's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive AB Science alpha.

AB Science Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for AB Science Stock analysis

When running AB Science's price analysis, check to measure AB Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AB Science is operating at the current time. Most of AB Science's value examination focuses on studying past and present price action to predict the probability of AB Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AB Science's price. Additionally, you may evaluate how the addition of AB Science to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Commodity Directory
Find actively traded commodities issued by global exchanges
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device